Thomas M Kündig,Ludger Klimek,Philipp Schendzielorz et al.
Thomas M Kündig et al.
Immunotherapy for type I allergies is well established and is regarded to be the most efficient treatment option besides allergen avoidance. As of today, different forms of allergen preparations are used in this regard, as well as different...
Monali Manohar,Kari C Nadeau
Monali Manohar
Edwin H Kim,Wesley Burks
Edwin H Kim
Allergic diseases have continued to increase throughout the developed world. Subcutaneous immunotherapy has been a mainstay of treatment for allergic rhinitis and asthma, however, some patients are precluded from treatment. On the other han...
Gabriela Senti,Seraina von Moos,Thomas M Kündig
Gabriela Senti
IgE-mediated allergies today affect up to 30 % of the population in industrialized countries. Allergen immunotherapy is the only disease-modifying treatment option with a long-term effect. However, very few patients (
Marek Jutel
Marek Jutel
Current asthma therapies can effectively control symptoms and the on-going inflammatory process; however, they do not affect the underlying, dysregulated immune response. Thus, they are limited to blunting the progression of the disease, wh...
Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy [0.03%]
用于过敏原特异性免疫治疗的过敏原肽、重组过敏原和低变应原性分子
Katharina Marth,Margarete Focke-Tejkl,Christian Lupinek et al.
Katharina Marth et al.
Allergic diseases are among the most common health issues worldwide. Specific immunotherapy has remained the only disease-modifying treatment, but it is not effective in all patients and may cause side effects. Over the last 25 years, aller...